Dr. Shintaro Hagiwara is a Risk Analyst and Statistician at Risk Sciences International (RSI), where he contributes cutting-edge statistical insight to risk assessments, particularly in chemical safety and public health. Since joining RSI’s technical team in 2018 and transitioning to a full-time role in 2023, he has applied his deep quantitative knowledge to building theoretical foundations and developing statistical software. Notably, he created the database-calibrated assessment process (DCAP) and the enhanced value-of-information (VOI) framework to aid in evidence-based regulatory decision-making, both of which have been reviewed by the board of scientific counselors (BOSC). His applied statistical work provides assessments and tools to derive PODs for chemicals such as inorganic arsenic and fluoride to support both Canadian and international regulatory bodies.

Margaret Wilson holds a BSc, BEd, and MSc in Molecular Biology, with post-graduate certificates in Population Health Risk Assessment and Management. She has worked extensively in health risk research, from BSE risk management to foodborne hazards. Currently at RSI, her focus includes risk prioritization and addressing challenges related to climate change. Margaret's multidisciplinary background equips her to tackle complex risk issues effectively.

Dr. Paul Stanish joined Risk Sciences International (RSI) in 2021 as a Risk Analyst, where he plays an essential role in advancing data-driven risk practices. Leveraging his strong background in chemistry and nanotechnology, he supports clients in building modern data cultures grounded in causal inference, machine learning operations (MLOps), and organizational performance measurement. His work ensures that risk frameworks not only incorporate emerging technologies but are also scalable and operational within institutional settings.

Dr. William Leiss held the NSERC/SSHRC Research Chair in Risk Communication and Public Policy at the Haskayne School of Business, University of Calgary, from 1999 to 2005. He has a substantial consulting background, collaborating with industry and various Canadian government departments on risk communication, risk management, public consultation, and multi-stakeholder consensus-building processes. Dr. Leiss has provided expertise on diverse issues, including pesticides, toxic chemicals, tobacco, prescription drugs, electric & magnetic fields, and genetic engineering. He earned his PhD from the University of California at San Diego.

Excerpt: Andrew Maw, an Associate Expert at Risk Sciences International (RSI), specializes in digital service delivery, data-driven risk modeling, and regulatory transformation. With extensive experience as a senior executive in the Canadian federal public service, he helps clients transition to risk-based compliance models, leveraging advanced analytics, machine learning, and business transformation strategies to enhance decision-making and operational effectiveness.

Dr. Anne Wiles joined Risk Sciences International (RSI) in 2008, where she currently serves as a Senior Analyst specializing in risk communication, perception, and governance. With a distinctive blend of expertise in language, regulation, and the use of science in decision-making, Anne has contributed to a wide range of RSI projects focused on the human and institutional dimensions of risk. Her work includes developing health risk communication strategies and drafting publicly accessible scientific information, advising on public messaging for nuclear energy and nuclear waste management, and supporting regulatory agencies in the evaluation and management of complex risk portfolios. She has been deeply involved in several RSI projects examining how mandates, institutional contexts, and public attitudes shape regulatory decision-making across federal domains. Anne has also contributed to scholarly work at RSI, including co-authoring a scoping review on the evolution of health and environmental risk decision-making, an article on the potential health risks associated with aluminum, and a book chapter on public concerns related to blood safety. In addition to her project work, Anne is a university instructor, teaching two courses: a broad overview of societal approaches to risk, and a graduate seminar on risk management in government, where she integrates academic theory with real-world regulatory case studies and risk communication practice.

Daniel Krewski began his career in the federal government of Canada, focusing on programs within Health Canada, particularly in food safety and environmental health. Trained in mathematics, statistics, and biostatistics, his multidisciplinary background reflects the complex nature of risk science. He later transitioned to academia, founding the McLaughlin Centre for Population Health Risk Assessment at the University of Ottawa. There, he developed new methodologies and collaborated internationally. In 2006, he co-founded Risk Sciences International, aiming to provide expert advice on diverse risk issues. His contributions have been instrumental in shaping risk assessment frameworks used by organizations like Health Canada and the U.S. Environmental Protection Agency. In 2023, Dr. Krewski passed the CEO's baton to Greg Paoli; he remains active as RSI Chief Risk Scientist.

Greg Paoli earned both his Bachelor's and Master's degrees from the University of Waterloo, specializing in engineering and systems design. His early career involved diverse research projects at the University of Waterloo's Institute for Risk Research. Greg later founded Decisionalysis Risk Consultants in 1997 and co-founded Risk Sciences International in 2006. He has served on multiple high-profile committees, including those under the U.S. National Academy of Sciences. As CEO of Risk Sciences International, Greg focuses on risk-based regulatory transformations and has developed enabling technologies like FDA-iRISK. His work spans various sectors, from food and chemical safety to public health, and he continues to contribute to the advancement of risk-based decision-making methodologies.

Dr. Arnold, a former general surgeon and occupational health consultant in Labrador and Nouveau Quebec, served Quebec Cartier Mining Ltd and the Iron Ore Company of Canada from 1973 to 1981. He has held teaching positions at various Canadian medical faculties and currently serves as an Adjunct Professor at McGill University. Dr. Arnold earned his M.D. from Queen's University in 1968 and has an extensive publication and presentation record with over 100 papers. He has received numerous honors for his contributions to occupational health and workplace psychological health and safety.

Emma Hartnett is an internationally recognized expert in risk assessment, specializing in toxicological, microbiological, and nutritional hazards. She holds a B.Sc. in Microbiology and a Ph.D. in Statistics and Modelling Science, where her thesis work focused on quantitative risk assessment for campylobacter infection from chicken. Hartnett has developed a variety of decision support tools addressing issues from infectious diseases to bioterrorism preparedness. She frequently contributes to WHO and FAO initiatives, and has been selected for the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment Roster of Experts for 2018-2022.